ASTELLAS FDA Approval NDA 020059

NDA 020059

ASTELLAS

FDA Drug Application

Application #020059

Documents

Letter2001-08-31
Letter2014-08-21
Label2014-01-07
Letter2005-07-21
Letter2010-01-19
Letter2014-01-07
Letter2014-08-21
Other Important Information from FDA2013-12-27
Label2003-04-30
Label2009-11-19
Label2014-08-22
Label2014-08-22
Review2004-05-25

Application Sponsors

NDA 020059ASTELLAS

Marketing Status

Discontinued001
Discontinued002

Application Products

001SOLUTION;INTRAVENOUS60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1ADENOSCANADENOSINE
002SOLUTION;INTRAVENOUS90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1ADENOSCANADENOSINE

FDA Submissions

TYPE 6; Type 6 - New Indication (no longer used)ORIG1AP1995-05-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-10-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1997-01-07STANDARD
LABELING; LabelingSUPPL4AP1997-12-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1998-09-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-10-26STANDARD
EFFICACY; EfficacySUPPL7AP2001-08-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-02-01STANDARD
LABELING; LabelingSUPPL11AP2005-07-14STANDARD
LABELING; LabelingSUPPL14AP2009-11-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2013-12-09STANDARD
LABELING; LabelingSUPPL16AP2014-01-03STANDARD
LABELING; LabelingSUPPL17AP2014-08-20STANDARD
LABELING; LabelingSUPPL18AP2014-08-20STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL8Null0
SUPPL14Null7
SUPPL15Null0
SUPPL16Null15
SUPPL17Null15
SUPPL18Null6

CDER Filings

ASTELLAS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20059
            [companyName] => ASTELLAS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ADENOSCAN","activeIngredients":"ADENOSINE","strength":"60MG\/20ML (3MG\/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"ADENOSCAN","activeIngredients":"ADENOSINE","strength":"90MG\/30ML (3MG\/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"08\/20\/2014","submission":"SUPPL-18","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020059s017s018lbl.pdf\"}]","notes":""},{"actionDate":"08\/20\/2014","submission":"SUPPL-17","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020059s017s018lbl.pdf\"}]","notes":""},{"actionDate":"01\/03\/2014","submission":"SUPPL-16","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020059s016lbl.pdf\"}]","notes":""},{"actionDate":"11\/06\/2009","submission":"SUPPL-14","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020059s014lbl.pdf\"}]","notes":""},{"actionDate":"08\/31\/2001","submission":"SUPPL-7","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20059s7lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ADENOSCAN","submission":"ADENOSINE","actionType":"60MG\/20ML (3MG\/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"ADENOSCAN","submission":"ADENOSINE","actionType":"90MG\/30ML (3MG\/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"SOLUTION;INTRAVENOUS","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-08-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.